Episode Details

In this episode of TDR Cannabis in Five, host Shadd Dales breaks down a growing question in the cannabis industry: can federal cannabis rescheduling still move forward during a time of geopolitical conflict?With global tensions escalating, oil prices reacting, and concerns rising about inflation and supply chain risk, investors are reassessing market exposure across sectors. Naturally, that has led to speculation about whether cannabis reform — specifically the potential rescheduling of marijuana under the Controlled Substances Act — could be delayed.This episode explains the difference between political focus and legal authority. Cannabis rescheduling is an administrative process led by the Department of Justice and the DEA, based on scientific review from Health and Human Services. It does not require Congress and does not legally pause during wartime or international instability.Shadd outlines how past conflicts did not halt federal rulemaking, what matters procedurally in the rescheduling process, and how macroeconomic volatility could actually increase the importance of 280E tax relief for U.S. operators.For cannabis investors watching both Washington and global markets, this episode separates legal fact from market narrative — and explains what truly determines whether rescheduling hits the Federal Register.#CannabisRescheduling #ScheduleIII #CannabisStocks #280E #FederalReform #DEA #DOJ #CannabisInvesting #MacroMarkets #CannabisPolicy #IranWar #Israel Want to see more Cannabis Reform videos?🎬    • Federal Hemp Ban: What’s Actually Targeted...  🎬    • Virginia Adult-Use Sales Finally Near | TD...  🎬    • Hemp THC Delay Won’t Get A Vote | TDR Cann...  🎬    • Pennsylvania Legalization Gains Real Momen...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:

Listen Now